Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
F. Kommoss, Anthony N. Karnezis, Friedrich Kommoss, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 4, pp. 480-486
Open Access | Times Cited: 117

Showing 26-50 of 117 citing articles:

Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer
Elisa D’Agostino, Luciana Mastrodomenico, Ornella Ponzoni, et al.
Cancer Treatment Reviews (2024) Vol. 126, pp. 102723-102723
Closed Access | Times Cited: 5
Reclassifying endometrial carcinomas with a combined morphological and molecular approach
Joseph W. Carlson, W. Glenn McCluggage
Current Opinion in Oncology (2019) Vol. 31, Iss. 5, pp. 411-419
Closed Access | Times Cited: 41
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma
Antonella Ravaggi, Davide Capoferri, Laura Ardighieri, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5429-5429
Open Access | Times Cited: 20
Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape
Amy Jamieson, Lisa Barroilhet, Jessica N. McAlpine
Cancer (2022) Vol. 128, Iss. 15, pp. 2853-2857
Closed Access | Times Cited: 19
A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation
Xi Chen, Xin Liu, Qian-hui Li, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Fertility Preservation in Endometrial Cancer—Treatment and Molecular Aspects
Melanie Schubert, Liselotte Mettler, Aarti Deenadayal Tolani, et al.
Medicina (2023) Vol. 59, Iss. 2, pp. 221-221
Open Access | Times Cited: 12
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?
Haider Mahdi, Isabelle Ray‐Coquard, Domenica Lorusso, et al.
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 11, pp. 1675-1681
Open Access | Times Cited: 12
Low-Risk and High-Risk NSMPs: A Prognostic Subclassification of No Specific Molecular Profile Subtype of Endometrial Carcinomas
Matteo Marchetti, Giulia Spagnol, Tommaso Vezzaro, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3221-3221
Open Access | Times Cited: 4
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma
Nicole Concin, François Planchamp, Nadeem R. Abu‐Rustum, et al.
International Journal of Gynecological Cancer (2021) Vol. 31, Iss. 12, pp. 1508-1529
Open Access | Times Cited: 27
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
Stephanie Vrede, Willem Jan van Weelden, Nicole C.M. Visser, et al.
Gynecologic Oncology (2021) Vol. 161, Iss. 3, pp. 787-794
Open Access | Times Cited: 26
Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework
Valentina Bruno, Martina Betti, Lorenzo D’Ambrosio, et al.
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 11, pp. 1708-1714
Open Access | Times Cited: 10
The impact of integrated genomic analysis on molecular classifications and prognostic risk stratification in endometrial cancer: a Chinese experience
Qian Zheng, Ди Шао, Shu Jin, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Comparative analysis of European guideline-based clinicopathological risk groups and the International Federation of Gynecology and Obstetrics staging system for endometrial cancer
Mikko Loukovaara, Annukka Pasanen, Heini Lassus, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2025) Vol. 308, pp. 85-89
Open Access
Molekulare und immunhistochemische Parameter zur Klassifikation des Endometriumkarzinoms
Gerhard Gebauer
Die Gynäkologie (2025)
Closed Access
Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry
Kazuhisa Hachisuga, Minoru Kawakami, Hiroshi Tomonobe, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 671-671
Open Access
Proteomic Changes Associated With Endogenous FBXW7 Mutations in Moderately Differentiated Endometrial Cancer Cells Include Increased TROP2 and Galectin‐3 Levels
Mary Ellen Urick, Suresh Kumar Chalapareddy, Eun‐Jeong Yu, et al.
Cancer Medicine (2025) Vol. 14, Iss. 6
Open Access
Morphological, immunohistochemical and molecular analysis of follicular dendritic cell sarcomas: L1CAM as a new diagnostic marker
Selina Schelbert, Katja Maurus, Sabine Roth, et al.
Histopathology (2025)
Open Access
Integrative analysis of DNA methylation, RNA sequencing, and genomic variants in the cancer genome atlas (TCGA) to predict endometrial cancer recurrence
Jin Hwa Hong, Yung‐Taek Ouh, Sohyeon Jeong, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Progress in the Study of Prognostic Factors and Risk Stratification in Early-Stage Endometrial Cancer: From Clinical Pathology to Molecular Integration
鑫华 叶
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 3437-3445
Closed Access
Molecular subgroup-specific prognostic value of semiquantitative lymphovascular space invasion in early-stage endometrioid endometrial cancer
Mikko Loukovaara, Annukka Pasanen, Ralf Bützow
Gynecologic Oncology (2025) Vol. 197, pp. 96-101
Closed Access
Identification of a very-high risk subgroup of localized endometrial carcinoma before surgery using circulating tumor DNA: a proof-of-concept study
Antoine Gaudet Chardonnet, Bruno Borghese, Jérôme Alexandre, et al.
International Journal of Gynecological Cancer (2025), pp. 101941-101941
Closed Access
Adjuvant treatment for endometrial cancer
Günter Emons, Dirk Vordermark
Current Opinion in Oncology (2019) Vol. 31, Iss. 5, pp. 404-410
Closed Access | Times Cited: 27
The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis—A Systematic Review
Klaudia Klicka, Tomasz M. Grzywa, Alicja Klinke, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3393-3393
Open Access | Times Cited: 21
Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer
Marta Mendiola, Teijo Pellinen, Jorge Luis Ramón-Patiño, et al.
Modern Pathology (2021) Vol. 35, Iss. 2, pp. 256-265
Open Access | Times Cited: 21
Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma
Guillaume Beinse, Bruno Borghese, Marie Métairie, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 6, pp. 782-793
Open Access | Times Cited: 16

Scroll to top